The Effect of Tenofovir on Vitamin D Metabolism in HIV-Infected Adults Is Dependent on Sex and Ethnicity

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Klassen, Karen ^a,b   Martineau, Adrian R ^c,d   Wilkinson, Robert J ^c,e   Cooke, Graham ^c   Courtney, Alan P ^b   Hickson, Mary ^b  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CORTICOSTEROID; DIDANOSINE; EFAVIRENZ; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR DISOPROXIL; VITAMIN D; ZIDOVUDINE;

ADULT; AGE; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; ETHNICITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; NEGRO; OSTEOPENIA; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PHOSPHATE EXCRETION; PROSPECTIVE STUDY; SEX DIFFERENCE; SIDE EFFECT; UNITED KINGDOM; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

ADENINE; ADULT; ANTI-HIV AGENTS; BONE DENSITY; CALCIUM; COHORT STUDIES; ETHNIC GROUPS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHONATES; PARATHYROID HORMONE; PHOSPHATES; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SEX FACTORS; VITAMIN D;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84866317738     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044845     Document Type: Article

References (29)

1. Brown T, Qaqish R, (2006) Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 20: 2165-2174.
2. Fausto A, Bongiovanni M, Cicconi P, Menicagli L, Ligabò EV, et al. (2006) Potential predictive factors of osteoporosis in HIV-positive subjects. Bone 38: 893-897.
3. Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, et al. (2004) Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA 292: 191-201.
4. Stellbrink HJ, Orkin C, Arribas JR, Compston J, Gerstoft J, et al. (2010) Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study. Clin Infect Dis 51: 963-972.
5. van Vonderen MG, Lips P, van Agtmael MA, Hassink EA, Brinkman K, et al. (2009) First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir. AIDS 23: 1367-1376.
6. Izzedine H, Harris M, Perazella M, (2009) The nephrotoxic effects of HAART. Nat Rev Nephrol 5: 563-573.
7. Saidenberg-Kermanac'h N, Souabni L, Prendki V, Prie D, Boissier MC, (2011) Normal plasma FGF23 levels kinetic in tenofovir-related hypophosphatemic osteomalacia in an HIV-infected patient with von Recklinghausen disease. Joint Bone Spine 78: 306-308.
8. Perrot S, Aslangul E, Szwebel T, Caillat-Vigneron N, Le Jeunne C, (2009) Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient. J Clin Rheumatol 15: 72-74.
9. Childs K, Fishman S, Constable C, Gutierrez J, Wyatt C, et al. (2010) Short communication: Inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users. AIDS Res Hum Retroviruses 26: 855-859.
10. Masiá M, Padilla S, Robledano C, López N, Ramos JM, et al. (2012) Early changes in parathyroid hormone concentrations in HIV-infected patients initiating antiretroviral therapy with tenofovir. AIDS Res Hum Retroviruses 28: 242-246.
11. Rosenvinge M, Gedela K, Copas A, Wilkinson A, Sheehy C, et al. (2010) Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency. J Acquir Immune Defic Syndr 54: 496-499.
12. Nelson M, Hague GF, Cooper C, Bunker VW, (1988) Calcium intake in the elderly: validation of a dietary questionnaire. J Hum Nutr Diet 1: 115-127.
13. Hyppönen E, Power C, (2007) Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 85: 860-868.
14. Health Do (1991) Dietary reference values for food energy and nutrients in the United Kingdom. Report of the panel on Dietary Reference Values of the Committee on Medical Aspect of Food Policy. London: HMSO.
15. Maunsell Z, Wright DJ, Rainbow SJ, (2005) Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clinical chemistry 51: 1683-1690.
16. Mawer EB, Berry JL, Cundall JP, Still PE, White A, (1990) A sensitive radioimmunoassay using a monoclonal antibody that is equipotent for ercalcitriol and calcitriol (1,25-dihydroxy vitamin D2 and D3). Clin Chim Acta 190: 199-209.
17. Daria P, Laura C, Elena R, Davide M, Monica S, et al. (2011) Secondary hyperparathyroidism in HIV patients: is there any responsibility of highly active antiretroviral therapy? AIDS 25: 1430-1433.
18. Holick MF, (2007) Vitamin D deficiency. N Engl J Med 357: 266-281.
19. Mueller N, Fux C, Ledergerber B, Elzi L, Schmid P, et al. (2010) High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 24: 1127-1134.
20. Rodriguez-Novoa S, Labarga P, Soriano V, Egan D, Albalater M, et al. (2009) Predictors of Kidney Tubular Dysfunction in HIV-Infected Patients Treated with Tenofovir: A Pharmacogenetic Study. Clinical Infectious Diseases 48: E108-E116.
21. Bech A, Van Bentum P, Nabbe K, Gisolf J, Richter C, et al. (2012) Fibroblast growth factor 23 in hypophosphataemic HIV-positive adults on tenofovir. HIV Med.
22. Woodward CL, Hall AM, Williams IG, Madge S, Copas A, et al. (2009) Tenofovir-associated renal and bone toxicity. HIV Med 10: 482-487.
23. Williams J, Chadwick DR, (2006) Tenofovir-induced renal tubular dysfunction presenting with hypocalcaemia. The Journal of infection 52: e107-108.
24. Berndt T, Kumar R, (2009) Novel mechanisms in the regulation of phosphorus homeostasis. Physiology (Bethesda) 24: 17-25.
25. Burnett SM, Gunawardene SC, Bringhurst FR, Juppner H, Lee H, et al. (2006) Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 21: 1187-1196.
26. Prentice A, Ceesay M, Nigdikar S, Allen SJ, Pettifor JM, (2008) FGF23 is elevated in Gambian children with rickets. Bone 42: 788-797.
27. Hoare J, Henderson L, Bates C, Prentice A, Birch M, et al. (2004) The National Diet & Nutrition Survey: adults aged 19 to 64 years. London: TSO.
28. Aspray TJ, Yan L, Prentice A, (2005) Parathyroid hormone and rates of bone formation are raised in perimenopausal rural Gambian women. Bone 36: 710-720.
29. Heaney RP, Dowell MS, Hale CA, Bendich A, (2003) Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr. 22: 142-146.